Hyzaar Forte (Losartan Potassium, Hydrochlorothiazide)

Losartan potassium is an angiotensin II receptor blocker (ARB) that selectively inhibits the AT₁ receptors on vascular smooth muscle and adrenal tissue. This blockade prevents angiotensin II‑mediated vasoconstriction and aldosterone release, leading to relaxation of blood vessels and reduced sodium retention, which together contribute to a decrease in systemic blood pressure.

The specific dose of Hyzaar Forte is determined by the prescribing clinician based on the patient’s blood‑pressure profile, renal function, and concomitant therapies. Healthcare professionals select the appropriate strength and adjust the regimen as needed, following national prescribing guidelines and individual therapeutic response.

The safety of Hyzaar Forte in pregnancy has not been established, and the product is generally avoided because losartan may cause fetal toxicity. Limited data exist for breastfeeding; therefore, the medication should only be used if the potential benefit justifies the possible risk to the infant, and under close medical supervision.

To request Hyzaar Forte, visit the product page on gnhindia.com, submit an enquiry with the desired quantity, and provide institutional or trade credentials. GNH India works with hospitals, pharmacies and procurement teams worldwide, confirming eligibility, then replies with pricing, availability, shipping details—including any required cold‑chain or import documentation—and finalizes the order.

Compared with single‑agent therapies, the losartan‑hydrochlorothiazide combination offers dual mechanisms—vascular relaxation and diuresis—in a single tablet, which can improve adherence and provide greater blood‑pressure reduction. Unlike calcium‑channel blockers or beta‑blockers, it specifically targets the renin‑angiotensin system and sodium balance, making it a preferred choice for patients who need both an ARB and a thiazide diuretic.

Hyzaar Forte tablets should be stored at ambient temperature, below 25 °C (77 °F). Keep them in the original packaging to protect from moisture and light, and ensure the container is tightly closed. Do not store in areas of high humidity or extreme heat, and keep out of reach of children.

Hyzaar Forte is taken orally, usually once daily, with or without food, as directed by a healthcare professional. The tablet should be swallowed whole with a glass of water and not crushed or chewed. Patients should follow the prescriber’s instructions regarding timing and any necessary dose adjustments based on blood‑pressure monitoring.

The most serious adverse events include severe dehydration, acute kidney injury, and hyperkalemia, especially in patients with impaired renal function or those taking other potassium‑affecting drugs. Rapid drops in blood pressure can cause dizziness or fainting. Prompt medical attention is required if symptoms such as persistent weakness, swelling, or allergic reactions develop.

Hyzaar Forte is contraindicated in patients with known hypersensitivity to losartan, hydrochlorothiazide, or any component of the formulation. It should also be avoided in individuals with severe renal impairment, anuria, or those who are pregnant. Caution is advised for patients with hepatic disease, electrolyte disturbances, or a history of angio‑edema, and the medication should only be used under medical supervision in these cases.